Thomas Powles, MBBS, MRCP, MD is a Clinical Professor of Genitourinary Oncology (HCC) at Barts Cancer Institute, UK. www.bci.qmul.ac.uk
Professor Powles completed his medical school training at St Bartholomew’s Medical School, London in 1996, consequently training in medical oncology at Imperial College, London. Following on, he completed his post-graduate training in oncology in 2005, receiving an MD from the University of London in 2006.
Professor Powles’ main research focuses on bladder and renal cancers. He has held lead positions in 13 national and international clinical trials, and has played a huge role in the development of immune checkpoint inhibitors in renal cancer.
Currently, his focus is in testis cancer, researching into redefining the treatment of patients with relapsed disease as well as focusing on the mechanisms of resistance to therapy in urology cancer. Professor Powles is now also leading an international collaboration testing conventional dose therapy and high dose therapy.